↓ Skip to main content

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

Overview of attention for article published in New England Journal of Medicine, September 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
5 X users
patent
2 patents
f1000
1 research highlight platform

Citations

dimensions_citation
421 Dimensions

Readers on

mendeley
239 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
Published in
New England Journal of Medicine, September 2010
DOI 10.1056/nejmoa1005109
Pubmed ID
Authors

Scott D Solomon, Hajime Uno, Eldrin F Lewis, Kai-Uwe Eckardt, Julie Lin, Emmanuel A Burdmann, Dick de Zeeuw, Peter Ivanovich, Andrew S Levey, Patrick Parfrey, Giuseppe Remuzzi, Ajay K Singh, Robert Toto, Fannie Huang, Jerome Rossert, John J V McMurray, Marc A Pfeffer

Abstract

Non–placebo-controlled trials of erythropoiesis-stimulating agents (ESAs) comparing lower and higher hemoglobin targets in patients with chronic kidney disease indicate that targeting of a lower hemoglobin range may avoid ESA-associated risks. However, target-based strategies are confounded by each patient's individual hematopoietic response.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 239 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 2%
Australia 3 1%
Japan 3 1%
Italy 2 <1%
United Kingdom 1 <1%
Uruguay 1 <1%
Korea, Republic of 1 <1%
Denmark 1 <1%
Unknown 223 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 49 21%
Other 31 13%
Student > Ph. D. Student 26 11%
Student > Bachelor 25 10%
Professor > Associate Professor 16 7%
Other 51 21%
Unknown 41 17%
Readers by discipline Count As %
Medicine and Dentistry 134 56%
Agricultural and Biological Sciences 12 5%
Pharmacology, Toxicology and Pharmaceutical Science 11 5%
Nursing and Health Professions 10 4%
Biochemistry, Genetics and Molecular Biology 10 4%
Other 17 7%
Unknown 45 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2021.
All research outputs
#1,990,146
of 24,288,533 outputs
Outputs from New England Journal of Medicine
#13,449
of 31,757 outputs
Outputs of similar age
#6,427
of 88,604 outputs
Outputs of similar age from New England Journal of Medicine
#71
of 183 outputs
Altmetric has tracked 24,288,533 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,757 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 121.4. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,604 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 183 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.